

Evofem Biosciences, Inc., (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The Company’s first commercial product, Phexxi™ (lactic acid, citric acid and potassium bitartrate), is the first and only vaginal pH regulator approved in the United States for the prevention of pregnancy. The Company is also advancing EVO100 into Phase 3 clinical trials for the prevention of urogenital transmission of both Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women.
We will give women everywhere control of their sexual and reproductive health.
2 empleados en Evofem Biosciences han revisado Evofem Biosciences en varias dimensiones de la cultura corporativa, compartiendo sus opiniones entre calificaciones ejecutivas hasta el ritmo en el trabajo. La última revisión fue hace el mes pasado.
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health.









Lack of leadership. Very inexperienced.
Revisión de Liderazgo/Directiva · Publicado hace 3 años

Dejaremos saber a Evofem Biosciences que estos interesado en trabajar en la compania, manteniendo tu identidad personal anonima. Comparably le dara la oportunidad a Evofem Biosciences de contratarte. Cuando haya un puesto de trabajo que sea adecuado, haremos que se produzca la coincidencia.
| 50% | Promoters |
|---|---|
| 0% | Passives |
| 50% | Detractors |





Envíales una invitación para valorar la cultura de la empresa.